Ion Beam Applications SA (IBA), headquartered in Louvain-la-Neuve, Belgium, is a leading medical technology company founded in 1986 as a spin-off from the Cyclotron Research Center at UCLouvain. Employing around 2,000 people worldwide, IBA specializes in particle accelerator technology.
The company designs, produces, and services equipment for proton therapy—the most precise form of radiation cancer treatment—dosimetry and quality assurance tools, radiopharma solutions including cyclotrons for PET/SPECT isotopes, and industrial applications such as electron beam sterilization of medical devices. IBA holds a dominant market position in proton therapy systems and supports global advancements in nuclear medicine, including targeted therapies.
